DK0857065T3 - Anvendelse af 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen til profylakse og behandling af følgerne efter aku - Google Patents
Anvendelse af 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen til profylakse og behandling af følgerne efter akuInfo
- Publication number
- DK0857065T3 DK0857065T3 DK96945354T DK96945354T DK0857065T3 DK 0857065 T3 DK0857065 T3 DK 0857065T3 DK 96945354 T DK96945354 T DK 96945354T DK 96945354 T DK96945354 T DK 96945354T DK 0857065 T3 DK0857065 T3 DK 0857065T3
- Authority
- DK
- Denmark
- Prior art keywords
- ethoxycarbonylaminobenzene
- fluorobenzylamino
- acu
- prophylaxis
- consequences
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19539861A DE19539861A1 (de) | 1995-10-26 | 1995-10-26 | Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen |
PCT/DE1996/001951 WO1997015300A2 (de) | 1995-10-26 | 1996-10-15 | Verwendung von 4-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen zur prophylaxe und behandlung der folgen der akuten und chronischen zerebralen minderdurchblutung sowie neurodegenerativer erkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0857065T3 true DK0857065T3 (da) | 1999-10-18 |
Family
ID=7775835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96945354T DK0857065T3 (da) | 1995-10-26 | 1996-10-15 | Anvendelse af 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen til profylakse og behandling af følgerne efter aku |
Country Status (26)
Country | Link |
---|---|
US (2) | US5852053A (zh) |
EP (1) | EP0857065B1 (zh) |
JP (2) | JP4567101B2 (zh) |
KR (1) | KR100423823B1 (zh) |
AR (1) | AR004108A1 (zh) |
AT (1) | ATE178487T1 (zh) |
AU (1) | AU706735B2 (zh) |
BR (1) | BR9610899A (zh) |
CA (1) | CA2188841C (zh) |
CZ (1) | CZ291456B6 (zh) |
DE (2) | DE19539861A1 (zh) |
DK (1) | DK0857065T3 (zh) |
ES (1) | ES2131973T3 (zh) |
GR (1) | GR3030336T3 (zh) |
HU (1) | HU228014B1 (zh) |
ID (1) | ID16489A (zh) |
IL (1) | IL123523A (zh) |
NO (1) | NO316493B1 (zh) |
NZ (1) | NZ326754A (zh) |
PL (1) | PL185714B1 (zh) |
RU (1) | RU2201227C2 (zh) |
SK (1) | SK283222B6 (zh) |
TW (1) | TW457084B (zh) |
UA (1) | UA51681C2 (zh) |
WO (1) | WO1997015300A2 (zh) |
ZA (1) | ZA968991B (zh) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19539861A1 (de) * | 1995-10-26 | 1997-04-30 | Asta Medica Ag | Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen |
GB9915414D0 (en) * | 1999-07-01 | 1999-09-01 | Glaxo Group Ltd | Medical use |
US6472165B1 (en) * | 1999-08-03 | 2002-10-29 | Arzneimittelwerk Dresden Gmbh | Modulatory binding site in potassium channels for screening and finding new active ingredients |
US6117900A (en) * | 1999-09-27 | 2000-09-12 | Asta Medica Aktiengesellschaft | Use of retigabine for the treatment of neuropathic pain |
TWI287984B (en) | 2000-10-17 | 2007-10-11 | Wyeth Corp | Pharmaceutical composition for modulating bladder function |
US6589986B2 (en) * | 2000-12-20 | 2003-07-08 | Wyeth | Methods of treating anxiety disorders |
US20020183395A1 (en) * | 2001-04-04 | 2002-12-05 | Wyeth | Methods for treating hyperactive gastric motility |
US7205307B2 (en) * | 2002-02-14 | 2007-04-17 | Icagen, Inc. | Pyrimidines as novel openers of potassium ion channels |
PL377221A1 (pl) * | 2002-12-27 | 2006-01-23 | H. Lundbeck A/S | Pochodne 1,2,4-triaminobenzenu |
US7368472B2 (en) * | 2002-12-27 | 2008-05-06 | H. Lundbeck A/S | 1,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system |
AU2004233941A1 (en) * | 2003-04-25 | 2004-11-11 | H. Lundbeck A/S | Sustituted indoline and indole derivatives |
US20050089559A1 (en) * | 2003-10-23 | 2005-04-28 | Istvan Szelenyi | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
TWI349666B (en) | 2004-03-12 | 2011-10-01 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivatives |
US7812020B2 (en) | 2005-03-03 | 2010-10-12 | H. Lundbeck A/S | Substituted pyridine derivatives |
US7960436B2 (en) * | 2006-06-05 | 2011-06-14 | Valeant Pharmaceuticals International | Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators |
US20080045534A1 (en) * | 2006-08-18 | 2008-02-21 | Valeant Pharmaceuticals North America | Derivatives of 1,3-diamino benzene as potassium channel modulators |
US8993593B2 (en) * | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
AU2007288253B2 (en) * | 2006-08-23 | 2013-05-02 | Xenon Pharmaceuticals Inc. | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
US8722929B2 (en) * | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
KR20090083479A (ko) * | 2006-11-28 | 2009-08-03 | 밸리언트 파마슈티컬즈 인터내셔널 | 칼륨 채널 조절제로서의 1,4 디아미노 이환 레티가빈 유사체 |
US8367684B2 (en) * | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
US8563566B2 (en) | 2007-08-01 | 2013-10-22 | Valeant Pharmaceuticals International | Naphthyridine derivatives as potassium channel modulators |
US7786146B2 (en) * | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
JP2011528666A (ja) * | 2008-07-18 | 2011-11-24 | バレアント プハルマセウトイカルス インターナショナル | 放出調節製剤及びその使用方法 |
US20100323016A1 (en) * | 2008-07-18 | 2010-12-23 | Biljana Nadjsombati | Modified release formulation and methods of use |
US20100323015A1 (en) * | 2008-07-18 | 2010-12-23 | Biljana Nadjsombati | Modified release formulation and methods of use |
WO2013011518A1 (en) | 2011-07-21 | 2013-01-24 | Arch Pharmalabs Limited | Process for the preparation of retigabine of the formula i and pharmaceutically acceptable salts thereof |
CN103073455B (zh) | 2011-10-25 | 2015-08-19 | 中国科学院上海药物研究所 | 一类新型的kcnq钾通道激动剂、其制备方法和用途 |
CA2881464C (en) | 2012-08-07 | 2021-12-21 | Children's Medical Center Corporation | Potassium channel openers for treating neurodegenerative diseases |
CN105017085B (zh) | 2014-04-28 | 2018-06-29 | 中国科学院上海药物研究所 | 一类kcnq钾通道激动剂、其制备方法和用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2817334B2 (ja) * | 1990-03-29 | 1998-10-30 | 株式会社ツムラ | 神経細胞保護剤 |
DE4200259A1 (de) * | 1992-01-08 | 1993-07-15 | Asta Medica Ag | Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung |
DE4327516A1 (de) * | 1993-08-17 | 1995-02-23 | Asta Medica Ag | Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin |
TW280819B (zh) * | 1993-11-17 | 1996-07-11 | Sumitomo Pharma | |
DE19539861A1 (de) * | 1995-10-26 | 1997-04-30 | Asta Medica Ag | Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen |
-
1995
- 1995-10-26 DE DE19539861A patent/DE19539861A1/de not_active Withdrawn
-
1996
- 1996-10-15 SK SK520-98A patent/SK283222B6/sk not_active IP Right Cessation
- 1996-10-15 HU HU9900508A patent/HU228014B1/hu not_active IP Right Cessation
- 1996-10-15 BR BR9610899A patent/BR9610899A/pt not_active Application Discontinuation
- 1996-10-15 DK DK96945354T patent/DK0857065T3/da active
- 1996-10-15 KR KR10-1998-0702958A patent/KR100423823B1/ko not_active IP Right Cessation
- 1996-10-15 UA UA98052705A patent/UA51681C2/uk unknown
- 1996-10-15 WO PCT/DE1996/001951 patent/WO1997015300A2/de active IP Right Grant
- 1996-10-15 NZ NZ326754A patent/NZ326754A/xx not_active IP Right Cessation
- 1996-10-15 DE DE59601624T patent/DE59601624D1/de not_active Expired - Lifetime
- 1996-10-15 IL IL12352396A patent/IL123523A/en not_active IP Right Cessation
- 1996-10-15 AU AU15400/97A patent/AU706735B2/en not_active Ceased
- 1996-10-15 PL PL96325956A patent/PL185714B1/pl not_active IP Right Cessation
- 1996-10-15 RU RU98109951/14A patent/RU2201227C2/ru not_active IP Right Cessation
- 1996-10-15 JP JP51618597A patent/JP4567101B2/ja not_active Expired - Fee Related
- 1996-10-15 EP EP96945354A patent/EP0857065B1/de not_active Expired - Lifetime
- 1996-10-15 AT AT96945354T patent/ATE178487T1/de active
- 1996-10-15 ES ES96945354T patent/ES2131973T3/es not_active Expired - Lifetime
- 1996-10-15 CZ CZ19981225A patent/CZ291456B6/cs not_active IP Right Cessation
- 1996-10-21 TW TW085112851A patent/TW457084B/zh active
- 1996-10-24 ID IDP963059A patent/ID16489A/id unknown
- 1996-10-25 AR ARP960104912A patent/AR004108A1/es not_active Application Discontinuation
- 1996-10-25 CA CA002188841A patent/CA2188841C/en not_active Expired - Fee Related
- 1996-10-25 ZA ZA968991A patent/ZA968991B/xx unknown
- 1996-10-28 US US08/736,166 patent/US5852053A/en not_active Expired - Lifetime
-
1997
- 1997-09-25 US US08/937,420 patent/US5849789A/en not_active Expired - Lifetime
-
1998
- 1998-04-02 NO NO981503A patent/NO316493B1/no not_active IP Right Cessation
-
1999
- 1999-05-27 GR GR990401425T patent/GR3030336T3/el unknown
-
2008
- 2008-07-15 JP JP2008183440A patent/JP2009007366A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0857065T3 (da) | Anvendelse af 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen til profylakse og behandling af følgerne efter aku | |
DK0881881T3 (da) | Antiparasitært præparat til behandling og beskyttelse af kæledyr | |
DK1021410T3 (da) | Prostaglandinagonister og deres anvendelse til behandling af knogletilstande | |
DK0791190T3 (da) | Signaleringsgenstande og fremgangsmåde til fremstilling af samme | |
NO20002846D0 (no) | Inhaleringsanordning og fremgangsmÕte ved samme | |
DK0861081T3 (da) | Anvendelse af epinastin til behandling af smerter | |
DK0830864T3 (da) | Kombinationsbehandling til behandling af psykoser | |
NO983284D0 (no) | Antikoagolante midler egnet i behandling av trombose | |
DE69521107D1 (de) | Ausrichtverfahren und Halbleiterbelichtungsverfahren | |
DK0841946T4 (da) | Metoder til behandling af allergisk astma | |
MX9807473A (es) | Procedimiento para la obtencion de aminas y aminonitrilos. | |
DK0815922T3 (da) | Fremgangsmåde til afsvovling og decarbonisering | |
DK0831098T3 (da) | Mellemprodukter og fremgangsmåde til fremstilling af olanzapin | |
DE69417382D1 (de) | Beschichtungsverfahren und Beschichtungsvorrichtung | |
DK0805797T3 (da) | Fremgangsmåde til fremstilling af N-aryl- og N-hetarylhydroxylaminer | |
DK0898566T3 (da) | Substituerede benzylaminer og anvendelse deraf til behandling af depression | |
NO940801L (no) | Fremgangsmåte og komponenter for alternativ forskaling | |
NO973680D0 (no) | Fremgangsmåte for fremstilling av ikke-vandige dispersjoner og deres anvendelse | |
NO20001758D0 (no) | Fremgangsmåter og blandinger for behandling av leddgikt | |
DK15997A (da) | Indretning til opbevaring af tovværk og tilsvarende | |
DK0594528T3 (da) | Fremgangsmåde og anlæg til behandling af halve slagtekroppe | |
DK0981349T3 (da) | 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme | |
DK1011678T3 (da) | Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelser | |
DK0979083T3 (da) | Anvendelse af 1-ar(alk)yl-imidazolin-2-oner til behandling af angst- og stresstilstande | |
NO983388D0 (no) | Trifenylboran-kolofoniumaminaddukt og anvendelse derav |